Skip to main content

Table 1 Patient characteristics following myocardial infarction stratified by prior cardiovascular disease, diabetes, and chronic kidney disease

From: Risk for recurrent cardiovascular disease events among patients with diabetes and chronic kidney disease

  Prior CVD (n = 89,920)a Diabetes only (n = 46,032) CKD only (n = 13,459) Diabetes and CKD
(n = 13,319)
Age, years, mean (SD) 77.1 (10.3) 72.0 (11.3) 81.1 (9.7) 77.4 (8.9)
Cohort, %
 MarketScan 8.2 18.9 3.5 4.1
 Medicare 91.8 81.1 96.5 95.9
 Males, % 53.3 50.1 44.6 45.4
Race/ethnicity, %b
 Black, Non-hispanic 5.5 9.0 7.7 11.7
 White, Non-hispanic 90.4 82.8 87.7 80.1
 Other 4.0 8.0 4.7 8.1
Geographic region, %
 West 14.4 15.5 16.2 16.3
 Midwest 24.8 24.4 28.3 26.5
 Northeast 20.6 18.0 18.0 17.1
 South 40.2 42.1 37.5 40.0
Area-level income, %b
 < $35,000 7.9 9.7 7.6 10.4
 $35,000–$49,999 33.3 34.5 32.0 35.0
 $50,000–$74,999 36.8 36.6 39.6 36.5
 ≥ $75,000 22.0 19.2 20.8 18.2
 Smoking, % 49.3 40.2 41.2 40.1
 Hypertension, % 92.8 90.6 93.5 97.8
 History of heart failure, % 40.1 31.9 46.7 54.4
 Depression, % 30.2 25.8 28.3 30.3
 Prior MI hospitalization, % 18.9 0.0 0.0 0.0
 Prior CABG/PCI outside of an MI event, % 5.2 0.0 0.0 0.0
 CABG/PCI during the MI event related to the index date, % 52.0 66.5 45.7 51.3
 Cardiologist care, % 57.7 29.6 24.5 23.5
 Endocrinologist care, % 2.3 8.6 2.4 11.0
 Use of insulin, % 0.0 25.0 0.0 40.0
Statin use and intensity, %
 No statin 39.6 51.3 63.1 41.0
 Low 5.7 6.4 5.8 7.5
 Moderate 34.9 32.4 25.5 38.4
 High 19.8 9.9 5.6 13.1
 Ezetimibe use, % 4.2 2.3 1.6 2.9
 Antihypertensive medication use, % 93.0 91.4 92.5 95.7
  1. CABG coronary artery bypass graft, CKD chronic kidney disease, CVD cardiovascular disease, PCI percutaneous coronary intervention, MI myocardial infarction, SD standard deviation
  2. aThis group included patients with prior cardiovascular disease without diabetes or chronic kidney disease. Patients with prior cardiovascular disease and diabetes or chronic kidney disease were excluded from the analysis
  3. bAmong Medicare beneficiaries only